WorthPointe’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
BFS
II
OFS
PFG
PAW
UCFA
WorthPointe's IBD Position: Q2 2026 in Review
WorthPointe reduced its Inspire Corporate Bond ETF (IBD) stake by 26% in Q2 2026, selling an estimated $1.26M and leaving 154,171 shares worth $3.66M. The position accounts for 0.92% of the portfolio, ranked #23.
WorthPointe first reported a position in IBD in Q3 2023 and has held it in 5 quarters since. The position peaked at $7.56M in Q4 2025. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.
- WorthPointe held 154,171 shares of Inspire Corporate Bond ETF worth $3.66M as of Q2 2026.
- WorthPointe sold 52,796 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $1.26M.
- Inspire Corporate Bond ETF made up 0.92% of WorthPointe's portfolio in Q2 2026, its #23 holding.
- WorthPointe first reported a position in Inspire Corporate Bond ETF in Q3 2023 and has held it in 5 quarters since.
- WorthPointe's Inspire Corporate Bond ETF position peaked at $7.56M in Q4 2025.
- 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.
Based on WorthPointe's 13F filing for Q2 2026, filed 31 Jul 2026.